MindWalk Holdings Corp. (HYFT)
NASDAQ: HYFTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
HYFT stock chart
Technical analysisKey statistics
All statistics- Market cap
- $32.56M
- EPS (TTM)
- -$0.26
- Dividend yield
- None
- 52-week range
- 0.64 – 2.99
- Day range
- 0.64 – 0.7982
- Volume / Avg
- 693.54K / 257.86K
- Beta
- —
- Shares outstanding
- 47.57M
- Next earnings
- Dec 21, 2026
52-week range
HYFT stock today
Shares of MindWalk (HYFT) finished lower on Nov 20 at $0.6844, a drop of 14.27% or $0.1139 per share, versus the S&P 500's 3.70% decline. Volume was 2.7x the average at 693.54K shares, a sign of unusually heavy trading. Shares are 77.1% below their 52-week high of $2.99, set on Jan 12, 2026 and 6.9% above the 52-week low of $0.64, near the bottom of the past year's range.
HYFT is down 62.4% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 59.0%. MindWalk has posted a net loss over the last twelve months (EPS of -$0.26), so its P/E ratio is not meaningful. MindWalk's next earnings report is expected on Dec 21, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About MindWalk
Company profileMindWalk Holdings Corp. operates as a bio-native AI company. The company discovers and develops biologics through HYFT Technology and LensAI platform, as well as develops AI drug discovery and biologics through ReefIQ technology.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Dr. Jennifer Lynne Bath Ph.D.
- Headquarters
- Austin, TX
- Employees
- 74
- Website
- mindwalkai.com
Analyst forecast
ForecastConsensus (3 analysts)
none
Avg. price target
$4.33+532.67%
- Strong buy 0
- Buy 3
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Dec 21, 2026
- EPS estimate
- $-0.05
HYFT news
All HYFT news- MindWalk Holdings Corp. Announces Results of 2026 Annual General Meeting of ShareholdersNasdaqHYFT, MKC.V
- MindWalk Holdings Corp. Enters into $30.0 million Senior Unsecured Revolving Credit AgreementNasdaq
- MindWalk Holdings Corp. Announces Agreement with Teva Australia to Support Defined Antibody-Discovery WorkflowsNasdaq
- MindWalk Holdings Corp. Reports Termination of Chief Business Officer Thomas Lynch on October 16, 2026NasdaqHYFT, DDS
MindWalk peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| GRDXGridAI Technologies Corp. | 3.16 | -8.41% | $32.44M | vs HYFT |
| FLNAFilana Therapeutics Inc. | 0.6413 | +14.52% | $32.26M | vs HYFT |
| ATNMActinium Pharmaceuticals Inc. (Delaware) | 1.05 | -1.87% | $33.01M | vs HYFT |
| VERUVeru Inc. | 1.94 | -8.06% | $33.08M | vs HYFT |
| CUECue Biopharma Inc. | 4.15 | -7.78% | $34.69M | vs HYFT |
| SERSerina Therapeutics Inc. | 1.12 | -6.67% | $29.76M | vs HYFT |
| NXTCNextCure Inc. | 6.45 | -4.87% | $29.53M | vs HYFT |
| GRCEGrace Therapeutics Inc. | 1.71 | -0.58% | $35.97M | vs HYFT |
Indexes, lists and sector
MindWalk stock FAQ
What is MindWalk's stock price today?
HYFT last traded at $0.6844 as of Nov 20, 4:00 PM EST, down 14.27% on the day. Prices are delayed at least 15 minutes.
Does MindWalk pay a dividend?
No. MindWalk does not currently pay a regular cash dividend.
When is MindWalk's next earnings date?
MindWalk is expected to report earnings on Monday, December 21, 2026. Analysts expect EPS of $-0.05.
Who is MindWalk's CEO?
Dr. Jennifer Lynne Bath Ph.D. is the chief executive officer of MindWalk Holdings Corp., which has about 74 employees.
Has HYFT ever split its stock?
Yes. The most recent HYFT stock split was a 1-for-5 split on Nov 23, 2020, one of 3 splits on record.
What is the HYFT 52-week high?
The 52-week high for HYFT is $2.99 and the 52-week low is $0.64. The stock is currently 77.1% below its high.